Using a murine model of steatosis and diabetes, they also demonstrated that genetic deletion of PAR2 (PAR2-KO) improved histological markers of steatosis activity and led to a reduction in plasma glucose and insulin levels. This evidence concerns the gene F2RL1 and diabetes mellitus.